PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Explores the Cardiovascular Drugs Potential in KSA and UAE - A complimentary analyst briefing to be hosted on April 20 at 4:30 pm UAE time
Frost & Sullivan Explores the Cardiovascular Drugs Potential in KSA and UAE

 

NewswireToday - /newswire/ - Dubai, UAE, United Arab Emirates, 2011/04/19 - A complimentary analyst briefing to be hosted on April 20 at 4:30 pm UAE time.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Healthcare Practice at Frost & Sullivan, a Global Growth Partnership Company, is pleased to host an Analyst Briefing titled ‘Cardiovascular Drugs holds the potential in KSA and UAE: Know the market trends – current and future’, scheduled for Wednesday, April 20th, 2011 at 4:30 pm U.A.E Time.

The growing burden of Cardiovascular and allied diseases has ushered opportunity for pharmaceutical companies globally with their cardiovascular drug portfolio. To successfully foray and operate in any geographic market require an in-depth understanding of market dynamics, trends and future scenario of the market. This briefing aims to provide an in-depth coverage of the cardiovascular drugs market in private channel including segments such as anti-hypertensive and lipid lowering.

This briefing is going to benefit the companies who are either considering an entry into these markets or a new entrant with their cardiovascular product portfolio. Apart from pharmaceutical companies, channel partners and investors will derive benefit from such briefing.

Highlights of the briefing include analysis of external challenges such as drivers and restraints, revenue trends and forecast overall cardiovascular drugs market and its market segments.

According to Frost & Sullivan,“The KSA and UAE markets for cardiovascular drugs hold great potential for pharmaceutical companies with skewed demographic profile towards baby boomers, higher incidences of lifestyle diseases including cardiovascular ailments, diabetes, etc. and a prosperous economy. Frost & Sullivan’s latest analyst briefing will examine the value proposition offered by the KSA and UAE cardiovascular markets and evaluate their position as potential markets for pharmaceutical players.”

To participate in this briefing, or for an interview, please contact Tanu Chopra/ Nimisha Iyer at tanu.chopra[.]frost.com / niyer[.]frost.com with the following information: your full name, company name, title, telephone number, office email id, address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you. You may also register to receive a recorded version of the briefing by submitting the aforementioned details.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from 40 offices across six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Explores the Cardiovascular Drugs Potential in KSA and UAE

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Tanu Chopra / Nimisha Iyer 
+91.22. 6607 2037 / +91 98200 50519 tanu.chopra[.]frost.com / niyer[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)